Nokia sopimukseen Ranskan valtion kanssa johtavan, merenalaisten verkkojen ASN-liiketoiminnan myynnistä
27 juin 2024 02h00 HE
|
Nokia Oyj
Lehdistötiedote Nokia sopimukseen Ranskan valtion kanssa johtavan, merenalaisten verkkojen ASN-liiketoiminnan myynnistä Nokia ja Ranskan valtio ovat allekirjoittaneet myyntioption ASN:stä 350...
Nokia enters into an agreement with the French State regarding the sale of leading submarine networks business ASN
27 juin 2024 02h00 HE
|
Nokia Oyj
Press ReleaseNokia enters into an agreement with the French State regarding the sale of leading submarine networks business ASN Nokia has signed a put option agreement with the French State...
AmeriCorps Introduces Transformative Rule to Boost Grant Flexibility and Empower National Service Programs
28 mai 2024 10h28 HE
|
AmeriCorps
Washington, DC, May 28, 2024 (GLOBE NEWSWIRE) -- AmeriCorps, the federal agency for national service and volunteerism, announced a final rule for the AmeriCorps State and National program. This...
Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023
13 oct. 2023 16h30 HE
|
Travere Therapeutics, Inc.
Two late-breaking high-impact oral presentations of the Phase 3 PROTECT Study of FILSPARI® (sparsentan) in IgAN and Phase 3 DUPLEX Study of sparsentan in FSGS 11 total abstracts accepted for...
SeaStar Medical (Nasdaq: ICU) Announces Positive Interim Safety Findings from Ongoing Study Evaluating the Selective Cytopheretic Device (SCD) in Children
03 nov. 2022 09h00 HE
|
SeaStar Medical Holding Corporation
Data being presented at the American Society of Nephrology (ASN) Kidney Week 2022 Interim study data show that SCD treatment is safe to use in pediatric patients with Acute Kidney Injury (AKI)...
Travere Therapeutics Announces Presentations and Posters at American Society of Nephrology Kidney Week 2022
26 oct. 2022 16h30 HE
|
Travere Therapeutics, Inc.
SAN DIEGO, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company and its collaborators will present data from its sparsentan programs,...
FibroGen Announces Analyses from Roxadustat Global Phase 3 Program at American Society of Nephrology Kidney Week 2021
25 oct. 2021 07h00 HE
|
FibroGen, Inc.
SAN FRANCISCO, Oct. 25, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), today announced that analyses from the global Phase 3 roxadustat clinical program will be presented at the American...
Equillium Featured in Panel Discussion at Capital Markets Day for Kidney Health
15 nov. 2019 08h05 HE
|
Equillium
LA JOLLA, Calif., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat...
Apellis to Present Data on APL-2 in Complement 3 Glomerulopathy at ASN Kidney Week 2019
11 oct. 2019 16h01 HE
|
Apellis Pharmaceuticals, Inc.
Company also provides an update on plans in nephrology CRESTWOOD, Ky. and WALTHAM Mass., Oct. 11, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc. (Nasdaq: APLS), a clinical-stage...
Satellite Healthcare to Present at American Society of Nephrology Annual Kidney Week Conference
31 oct. 2017 09h03 HE
|
Satellite Healthcare
SAN JOSE, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading not-for-profit dialysis provider, today announced it will present three posters and host a NephTalk lounge for...